Zobrazeno 1 - 10
of 48
pro vyhledávání: '"B Wiechel"'
Publikováno v:
Vox Sanguinis. 68:22-26
We have modified previously described solid-phase tests for erythrocyte antibody screening to develop a method, suitable for antiglobulin- and enzyme-enhanced techniques (SPH-IAT and SPH-ENZ). In this study we compared the SPH tests with an autoanaly
Publikováno v:
Vox Sanguinis. 60:23-27
Bone marrow transplant recipients at Huddinge Hospital have routinely received single-donor platelet concentrates (PC) from blood group 0 donors. These PC contain approximately 350 ml plasma, which is incompatible with patients of group A, B and AB.
Publikováno v:
Vox Sanguinis. 60:23-27
Publikováno v:
Transfusion. 32(5)
The in vitro effect of 6-day storage of platelets prepared from 6 pooled buffy coat (BC) units and stored in a platelet storage medium containing approximately 40 percent CPD-plasma and 60 percent platelet additive solution (PAS) was evaluated. PAS i
Publikováno v:
Lakartidningen. 88(4)
Publikováno v:
Scandinavian Journal of Clinical and Laboratory Investigation. 47:561-566
A multicentre study was undertaken in order to determine the reliability of the methods of assay of F VIII:C and the position of the peak value obtained after infusion of F VIII:C concentrates. Blood samples were drawn before and 10, 30 and 60 min af
Publikováno v:
Lakartidningen. 76(51)
Autor:
G, Biberfeld, B, Böttiger, A, Karlsson, E, Sandström, L, Morfeldt-Månsson, M, Blombäck, I M, Nilsson, B, Wiechel, C, Saxinger, R, Gallo
Publikováno v:
Cancer research. 45
Two hundred and three homosexual (HS) men and 114 hemophiliacs in Sweden were examined for serum antibodies to human T-lymphotropic virus type III (HTLV-III) and for alterations of T-lymphocyte subsets. Sera were screened for HTLV-III antibodies by a
Autor:
B. Wiechel, Sture Larsson
Publikováno v:
Acta medica Scandinavica. 214(3)
One hundred and eighteen patients with hemophilia A or B died in Sweden between 1957 and 1980. The causes and circumstances of death have been the subject of a retrospective study. The most striking feature was the increase in age at death. In severe
Publikováno v:
Thrombosis and Haemostasis.
DDAVP fraction I-0 was prepared from a plasma pool derived from 80 blood donors who had received DDAVP and tranexamic acid. A control fraction I-0 was prepared from a plasma pool from the same group of blood donors under identical conditions except f